NIH, FDA Announcements Aim to Bolster Animal Alternatives

ABSTRACT: The FDA and NIH have announced new steps to reduce animal use in research. The FDA provided the first guidance for evaluating non-animal alternatives, or new approach methodologies (NAM), for drug pharmacology and toxicology. The NIH is providing more than $150 million for new centers and projects to develop and implement additional NAMs. But cancer researchers say that alternative approaches aren't ready to replace animal models.